Hereditary Leiomyomatosis and Renal Cell Cancer: A Syndrome Associated With an Aggressive Form of Inherited Renal Cancer

Journal of Urology

Volumn 177, Issue 6, 2007, Pages 2074-2080

  Grubb III, Robert L ^a   Franks, Michael E ^a   Toro, Jorge ^a   Middelton, Lindsay ^a   Choyke, Lynda ^a   Fowler, Sarah ^a   Torres Cabala, Carlos ^a   Glenn, Gladys M ^a   Choyke, Peter ^a   Merino, Maria J ^a   Zbar, Berton ^a   Pinto, Peter A ^a   Srinivasan, Ramaprasad ^a   Coleman, Jonathan A ^a   Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

carcinoma; fumarate hydratase; kidney; leiomyoma; papillary; uterus

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; KIDNEY METASTASIS; LEIOMYOMATOSIS; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RADIODIAGNOSIS; SEX DIFFERENCE; SURGICAL TECHNIQUE; UTERUS MYOMA;

ADULT; AGED; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; LEIOMYOMATOSIS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; PEDIGREE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 34248336258     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.01.155     Document Type: Article

References (16)

1. Kiuru M., Launonen V., Hietala M., Aittomaki K., Vierimaa O., Salovaara R., et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol 159 (2001) 825
2. Launonen V., Vierimaa O., Kiuru M., Isola J., Roth S., Pukkala E., et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 98 (2001) 3387
3. Tomlinson I.P., Alam N.A., Rowan N.A., Barclay E., Jaeger E.E., Kelsell D., et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30 (2002) 406
4. Toro J.R., Nickerson M.L., Wei M.H., Warren M.B., Glenn G.M., Turner M.L., et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73 (2003) 95
5. Wei M.-H., Toure O., Glenn G.M., Steinbach P., Stolle C., Choyke P., et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43 (2005) 18
6. Isaacs J.S., Jung Y.J., Mole D.R., Lee S., Torres-Cabala C., Chung Y.L., et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8 (2005) 143
7. Linehan W.M., Walther M.M., and Zbar B. The genetic basis of cancer of the kidney. J Urol 170 (2003) 2163
8. Walther M.M., Choyke P.L., Glenn G.M., Lyne J.C., Rayford W., Venzon D., et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161 (1999) 1475
9. Herring J.C., Enquist E.G., Chernoff A.C., Linehan W.M., Choyke P.L., and Walther M.M. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma-10-year experience. J Urol 165 (2001) 777
10. Duffey B.G., Choyke P.L., Glenn G., Grubb R.L., Venzon D., Linehan W.M., et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau Disease. J Urol 172 (2004) 63
11. Pavlovich C.P., Grubb R.L., Hurley K., Glenn G.M., Toro J., Schmidt L.S., et al. Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol 173 (2005) 1482
12. Linehan W.M., Yang J.C., and Bates S.E. Cancer of the kidney. In: DeVita S.E., Hellman S., and Rosenberg S.A. (Eds). Cancer Principles and Practice of Oncology. 7th ed. (2005), Lippincott Williams & Wilkins, Philadelphia 1139-1168 chapt 30
13. Merino M.J., Torres-Cabala C.A., Zbar B., Chian-Garcia C.A., and Linehan W.M. Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): clinical, histopathological and molecular features of the first American families described. Mod Pathol 16 suppl (2003) 739
14. Walther M.M., Choyke P.L., Weiss G., Manolatos C., Long J., Reiter R., et al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma. J Urol 153 (1995) 913
15. Vasselli J.R., Yang J.C., Linehan W.M., White D.E., Rosenberg S.A., and Walther M.M. Lack of Retroperitoneal lymphadenopathy predicts survival and response to IL-2 in patients with metastatic renal cell carcinoma. J Urol 166 (2001) 68
16. Pithukpakorn M., Wei M.H., Toure O., Steinbach P.J., Glenn G.M., Zbar B., et al. Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43 (2006) 755